Development and validation of the QUECOMIICAT questionnaire: a tool to assess disease-related knowledge in patients with inflammatory bowel disease
Por:
Casellas F, Navarro E, Amil P, Barber C, Marín L, Guardiola J, Espín E, Sainz E, Aldeguer X, Gallego M, Murciano F, García-Planella E, Martín-de-Carpi J, Mendive JM and González-Mestre A
Publicada:
1 ene 2019
Ahead of Print:
18 jul 2019
Resumen:
Introduction: adequate knowledge of inflammatory bowel disease (IBD) is essential for a successful patient-centered management of IBD.
Objective: due to the scarcity of up-to-date tools for measuring IBD literacy, this single-center, prospective study aimed to develop and validate a new questionnaire to assess IBD-related knowledge.
Material and methods: the study included patients followed up at the Crohn-Colitis Care Unit (UACC) at the Hospital Vall d'Hebron (Barcelona, Spain). Patients admitted to the UACC for the first time were subsequently enrolled into a standard IBD educational program. A pilot questionnaire was developed and validated in 92 IBD patients by determining the internal consistency reliability (Cronbach's alpha test), feasibility, construct validity (correlation with the Crohn's and Colitis Knowledge [CCKNOW] questionnaire and a knowledge visual analog scale [VAS]) and sensitivity (score change before and after a standard IBD educational program). The questionnaire, named "Questionari Coneixements Malaltia Inflamatoria Intestinal Catalunya" (IBD-knowledge questionnaire Catalonia) (QUECOMIICAT) was written in Spanish and had 25 items addressing six dimensions: general concepts, clinic, treatment, surgery, habits and social context.
Results: the median (interquartile range) completion time was 15 (10-20) minutes and the floor and ceiling effects were 1.1% and 2.1%, respectively. The Cronbach's alpha coefficient was alpha = 0.75. QUECOMIICAT significantly correlated with the VAS (rho = 0.34, p < 0.01) and CCKNOW questionnaires (rho = 0.74, p < 0.01). Patient knowledge significantly increased 24 hours after attending a standard IBD educational program and remained statistically significant one month later (Pearson's test-retest correlation coefficient r = 0.81, p < 0.001).
Conclusion: in conclusion, the QUECOMIICAT questionnaire is a new up-to-date tool to assess IBD-related knowledge with good feasibility and validation results for use in the routine clinical practice.
Filiaciones:
Casellas F:
Servicio de Digestivo, Hospital Universitari Vall d'Hebron, España
Navarro E:
Unitat Atenció Crohn-Colitis, Hospital Universitari Vall d'Hebrón
Amil P:
Programa Pacient Expert Catalunya®. Programa de pr, Direcció General de Planificació en Salut. Departament de Salut, Generalitat de Catalunya, Spain
Barber C:
Unitat Atenció Crohn-Colitis. , Hospital Universitari Vall d'Hebron, Barcelona, Spain
Marín L:
Hospital Universitari Germans Trias i Pujol. Badalona, Spain.
Guardiola J:
Hospital Universitari de Bellvitge. L'Hospitalet de Llobregat, Spain.
Espín E:
Unitat d'Atenció Crohn-Colitis, Hospital Universitari Vall d'Hebron. Barcelona, Spain
Sainz E:
Hospital Universitari Arnau de Vilanova. Lleida, Spain.
Aldeguer X:
Hospital Universitari Doctor Josep Trueta. Girona, Spain.
Gallego M:
Hospital Clínic i Provincial de Barcelona. Barcelona, Spain
Murciano F:
Hospital del Mar de Barcelona. Barcelona, Spain
García-Planella E:
Hospital de la Santa Creu i Sant Pau. Barcelona, Spain
Martín-de-Carpi J:
Hospital de Sant Joan de Deu. Barcelona, Spain.
Mendive JM:
CAP la Mina. SAP Litoral. Gerència d'Atenció Primària de Barcelona. Barcelona, Spain.
González-Mestre A:
Programa Pacient Expert Catalunya®. Programa de pr, Direcció General de Planificació en Salut. Departament de Salut, Generalitat de Catalunya, Spain
Green Published, gold
|